HealthcarePress Releases

Diabetes Devices Market Size – US$ 48.8 Bn By 2030

According to Precedence Research, The diabetes devices market size garnered US$ 48.8 billion in 2020 and is expected to generate US$ 26.7 billion by 2030, manifesting a CAGR of 5.4% from 2021 to 2030.  The report contains 150+ pages with detailed analysis.

The base year for the study has been considered 2021, the historic year 2019 and 2020, the forecast period considered is from 2021 to 2030. The diabetes devices market is analyzed on the basis of value (US$ Million), volume (Unit), and price (US$/Unit).

Download the FREE Sample Report (Including TOC, List of Tables & Figures, and Chart) @ https://www.precedenceresearch.com/sample/1321

Key Companies & Market Share Insights

The market is moderately fragmented with the presence of several local companies. These market players are striving to gain higher market share by adopting strategies, such as investments, partnerships, and acquisitions & mergers, novel product introductions and developments, promotion strategies and Research and Development (R&D) activities in the marketplace. Companies are also spending on the development of improved products. Moreover, they are also focusing on maintaining competitive pricing. The competitive profiling of these players includes business and financial overview, gross margin, production, sales, and recent developments which can aid in assessing competition in the market.

Some of the major players in the global diabetes devices market include:

  • B Braun Melsungen AG
  • Abbott Laboratories
  • Bayer AG
  • Medtronic Plc
  • F.Hoffman-La-Ltd.
  • Lifescan, Inc.
  • Dexcom, Inc.
  • Sanofi
  • Tandem Diabetes Care, Inc.
  • Companion Medical
Diabetes Devices Market Scope

This market report studies market dynamics, status and outlook especially in North America, Europe and Asia-Pacific, Latin America, the Middle East and Africa. This research report offers scenario and forecast (revenue/volume), and categorizes the market by key players and various segment. This report also studies global market prominence, competitive landscape, market share, growth rates market dynamics such as drivers, restraints and opportunities, and distributors and sales channels.

This research study also integrates Industry Chain analysis and Porter’s Five Forces Analysis. Further, this report offers a competitive scenario that comprises collaborations, market concentration rate and expansions, mergers & acquisitions undertaken by companies.

Crucial factors accountable for Diabetes Devices Market growth are:
  • Growing prevalence of diabetes
  • Unhealthy food habits and sedentary lifestyle
  • Growing awareness regarding diabetes control
  • Rapid growth of online pharmacy
  • Rapidly increasing diabetic population in underdeveloped and developing nations
  • Technological advancements and developments in the diabetes management devices
Diabetes Devices Market Report Highlights
  • By type, the insulin delivery devices segment led the global diabetes devices market owing to the higher adoption of insulin pen among the consumers. The convenience and comfort of injecting insulin helps to control diabetes in today’s busy and hectic lifestyle without applying much efforts.
  • By distribution channel, the hospital pharmacy segment led the global diabetes devices market with remarkable revenue share in 2020. The hospital pharmacists provide proper counseling to their patients regarding the product and their appropriate time to take medications. Hence, the diabetes related services provide by the pharmacists has fostered the segmental growth.
  • By end use, the hospital segment led the global diabetes devices market because most of the frequent hospital visits and admissions of the diabetic patients and hence, the use of diabetes device is more in hospitals.

Browse Healthcare Research Reports @ http://www.marketstatsnews.com/healthcare/

Diabetes Devices Market Dynamics

Drivers – The primary driver of the diabetes devices market is the rising prevalence of diabetes among the population. According to the WHO, the type 2 diabetes is the dominant type of diabetes that is affecting most of the people along with the children. Type 2 diabetes is a result of inactivity and excess weight of the body. Hence, the rising prevalence of type 2 diabetes is a major factor driving the growth of the market.

Restraints – The lack of awareness and low income of the people especially in the underdeveloped nations may act as a major constraint for the diabetes devices market.

Opportunities – The introduction of artificial intelligence in the diabetes devices is a key trend in the market. Eli Lilly and Bigfoot Biomedical entered into a partnership in 2019 to develop a system that uses artificial intelligence technology for dosing insulin.

Challenges – Lack of proper healthcare infrastructure and developed distribution channel in the emerging and underdeveloped markets is a major challenge posed against the market players.

Regional Snapshots

The global diabetes devices market is dominated by the North America, closely followed by Europe and Asia Pacific regions. North America is a matured market for the diabetes devices because a decline in the rate of diabetic population has been witnessed in the US since 2008. New diabetes cases in the US is prevailing among the Hispanic and non-Hispanic black population, the immigrant population. Increased awareness regarding diabetes, high disposable income, increasing consumer expenditure on healthcare products, developed healthcare infrastructure, and higher adoption rate of technologically advanced products in North America has exponentially contributed towards the growth of the diabetes devices market in the region.

The prevalence of type 2 diabetes is rapidly growing in the low and middle income countries that makes the Asia Pacific and Africa the most opportunistic market for the diabetes devices. Furthermore, rising government expenditure for the development of sophisticated healthcare infrastructure and increase in the marketing and promotional activities by the private brands is significantly grabbing the attention of the geriatric population and stimulating them to make a purchase of the diabetes device. Moreover, development of advanced and low cost devices is significantly boosting the adoption rate of the diabetes devices among the population.

Diabetes Devices Market Share, By Region, 2020 (%)

Diabetes Devices Market Segments Covered

By Type

  • Blood Glucose Monitoring
    • Self-Monitoring
    • Continuous Glucose Monitoring
  • Insulin Delivery Devices
    • Pens
    • Pumps
    • Jet Injectors
    • Syringes

By Distribution Channel

  • Retail Pharmacy
  • Hospital Pharmacy
  • Clinics
  • Online Pharmacy
  • Others

By End Use

  • Diagnostic Center
  • Hospitals
  • Home Care

By Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
  • Rest of the World

Research Objective

  • To provide a comprehensive analysis of the diabetes devices industry and its sub-segments in the global market, thereby providing a detailed structure of the industry
  • To provide detailed insights into factors driving and restraining the growth of this global market
  • To provide a distribution chain analysis/value chain for the this market
  • To estimate the market size of the global diabetes devices market where 2019 would be the historical period, 2020 shall be the base year, and 2020 to 2027 will be the forecast period for the study
  • To provide strategic profiling of key companies (manufacturers and distributors) present across the globe, and comprehensively analyze their competitiveness/competitive landscape in this market
  • To analyze the global market in four main geographies, namely, North America, Europe, Asia-Pacific, and the Rest of the World
  • To provide country-wise market value analysis for various segments of the diabetes devices
TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. Market Dynamics Analysis and Trends

5.1. Market Dynamics

5.1.1. Market Drivers

5.1.2. Market Restraints

5.1.3. Market Opportunities

5.2. Porter’s Five Forces Analysis

5.2.1. Bargaining power of suppliers

5.2.2. Bargaining power of buyers

5.2.3. Threat of substitute

5.2.4. Threat of new entrants

5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis

6.1.2. Key Strategies Adopted by Players

6.1.3. Vendor Landscape

6.1.3.1. List of Suppliers

6.1.3.2. List of Buyers

Chapter 7. Global Diabetes Devices Market, By Type

7.1. Diabetes Devices Market, by Type, 2021-2030

7.1.1. Blood Glucose Monitoring

7.1.1.1. Market Revenue and Forecast (2019-2030)

7.1.2. Insulin Delivery Devices

7.1.2.1. Market Revenue and Forecast (2019-2030)

Chapter 8. Global Diabetes Devices Market, By Application

8.1. Diabetes Devices Market, by Application, 2021-2030

8.1.1. Diagnostic Center

8.1.1.1. Market Revenue and Forecast (2019-2030)

8.1.2. Hospitals

8.1.2.1. Market Revenue and Forecast (2019-2030)

8.1.3. Home Care

8.1.3.1. Market Revenue and Forecast (2019-2030)

Chapter 9. Global Diabetes Devices Market, By Distribution Channel 

9.1. Diabetes Devices Market, by Distribution Channel, 2021-2030

9.1.1. Retail Pharmacy

9.1.1.1. Market Revenue and Forecast (2019-2030)

9.1.2. Hospital Pharmacy

9.1.2.1. Market Revenue and Forecast (2019-2030)

9.1.3. Clinics

9.1.3.1. Market Revenue and Forecast (2019-2030)

9.1.4. Online Pharmacy

9.1.4.1. Market Revenue and Forecast (2019-2030)

9.1.5. Others

9.1.5.1. Market Revenue and Forecast (2019-2030)

Chapter 10. Global Diabetes Devices Market, Regional Estimates and Trend Forecast

10.1. North America

10.1.1. Market Revenue and Forecast, by Type (2019-2030)

10.1.2. Market Revenue and Forecast, by Application (2019-2030)

10.1.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)

10.1.4. U.S.

10.1.4.1. Market Revenue and Forecast, by Type (2019-2030)

10.1.4.2. Market Revenue and Forecast, by Application (2019-2030)

10.1.4.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)

10.1.5. Rest of North America

10.1.5.1. Market Revenue and Forecast, by Type (2019-2030)

10.1.5.2. Market Revenue and Forecast, by Application (2019-2030)

10.1.5.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)

10.2. Europe

10.2.1. Market Revenue and Forecast, by Type (2019-2030)

10.2.2. Market Revenue and Forecast, by Application (2019-2030)

10.2.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)

10.2.4. UK

10.2.4.1. Market Revenue and Forecast, by Type (2019-2030)

10.2.4.2. Market Revenue and Forecast, by Application (2019-2030)

10.2.4.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)

10.2.5. Germany

10.2.5.1. Market Revenue and Forecast, by Type (2019-2030)

10.2.5.2. Market Revenue and Forecast, by Application (2019-2030)

10.2.5.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)

10.2.6. France

10.2.6.1. Market Revenue and Forecast, by Type (2019-2030)

10.2.6.2. Market Revenue and Forecast, by Application (2019-2030)

10.2.6.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)

10.2.7. Rest of Europe

10.2.7.1. Market Revenue and Forecast, by Type (2019-2030)

10.2.7.2. Market Revenue and Forecast, by Application (2019-2030)

10.2.7.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)

10.3. APAC

10.3.1. Market Revenue and Forecast, by Type (2019-2030)

10.3.2. Market Revenue and Forecast, by Application (2019-2030)

10.3.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)

10.3.4. India

10.3.4.1. Market Revenue and Forecast, by Type (2019-2030)

10.3.4.2. Market Revenue and Forecast, by Application (2019-2030)

10.3.4.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)

10.3.5. China

10.3.5.1. Market Revenue and Forecast, by Type (2019-2030)

10.3.5.2. Market Revenue and Forecast, by Application (2019-2030)

10.3.5.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)

10.3.6. Japan

10.3.6.1. Market Revenue and Forecast, by Type (2019-2030)

10.3.6.2. Market Revenue and Forecast, by Application (2019-2030)

10.3.6.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)

10.3.7. Rest of APAC

10.3.7.1. Market Revenue and Forecast, by Type (2019-2030)

10.3.7.2. Market Revenue and Forecast, by Application (2019-2030)

10.3.7.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)

10.4. MEA

10.4.1. Market Revenue and Forecast, by Type (2019-2030)

10.4.2. Market Revenue and Forecast, by Application (2019-2030)

10.4.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)

10.4.4. GCC

10.4.4.1. Market Revenue and Forecast, by Type (2019-2030)

10.4.4.2. Market Revenue and Forecast, by Application (2019-2030)

10.4.4.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)

10.4.5. North Africa

10.4.5.1. Market Revenue and Forecast, by Type (2019-2030)

10.4.5.2. Market Revenue and Forecast, by Application (2019-2030)

10.4.5.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)

10.4.6. South Africa

10.4.6.1. Market Revenue and Forecast, by Type (2019-2030)

10.4.6.2. Market Revenue and Forecast, by Application (2019-2030)

10.4.6.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)

10.4.7. Rest of MEA

10.4.7.1. Market Revenue and Forecast, by Type (2019-2030)

10.4.7.2. Market Revenue and Forecast, by Application (2019-2030)

10.4.7.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)

10.5. Latin America

10.5.1. Market Revenue and Forecast, by Type (2019-2030)

10.5.2. Market Revenue and Forecast, by Application (2019-2030)

10.5.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)

10.5.4. Brazil

10.5.4.1. Market Revenue and Forecast, by Type (2019-2030)

10.5.4.2. Market Revenue and Forecast, by Application (2019-2030)

10.5.4.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)

10.5.5. Rest of LATAM

10.5.5.1. Market Revenue and Forecast, by Type (2019-2030)

10.5.5.2. Market Revenue and Forecast, by Application (2019-2030)

10.5.5.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)

Chapter 11. Company Profiles

11.1. B Braun Melsungen AG

11.1.1. Company Overview

11.1.2. Product Offerings

11.1.3. Financial Performance

11.1.4. Recent Initiatives

11.2. Abbott Laboratories

11.2.1. Company Overview

11.2.2. Product Offerings

11.2.3. Financial Performance

11.2.4. Recent Initiatives

11.3. Bayer AG

11.3.1. Company Overview

11.3.2. Product Offerings

11.3.3. Financial Performance

11.3.4. Recent Initiatives

11.4. Medtronic Plc

11.4.1. Company Overview

11.4.2. Product Offerings

11.4.3. Financial Performance

11.4.4. Recent Initiatives

11.5. F.Hoffman-La-Ltd.

11.5.1. Company Overview

11.5.2. Product Offerings

11.5.3. Financial Performance

11.5.4. Recent Initiatives

11.6. Lifescan, Inc.

11.6.1. Company Overview

11.6.2. Product Offerings

11.6.3. Financial Performance

11.6.4. Recent Initiatives

11.7. Dexcom, Inc.

11.7.1. Company Overview

11.7.2. Product Offerings

11.7.3. Financial Performance

11.7.4. Recent Initiatives

11.8. Sanofi

11.8.1. Company Overview

11.8.2. Product Offerings

11.8.3. Financial Performance

11.8.4. Recent Initiatives

11.9. Tandem Diabetes Care, Inc.

11.9.1. Company Overview

11.9.2. Product Offerings

11.9.3. Financial Performance

11.9.4. Recent Initiatives

11.10. Companion Medical

11.10.1. Company Overview

11.10.2. Product Offerings

11.10.3. Financial Performance

11.10.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research

12.2. Secondary Research

12.3. Assumptions

Chapter 13. Appendix

13.1. About Us

13.2. Glossary of Terms

Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.

Why Buy this Report?

The purpose of Precedence Research’s diabetes devices market study is to provide stakeholders with a detailed picture of potential barriers and untapped opportunities. The report contains exclusive information to assist businesses in making informed decisions about how to maintain growth throughout the assessment period.

Buy Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1321

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://precedenceresearchnews.wordpress.com

Show More

Market Stats News

Market Stats News is a Canada/India based company and one of the leading providers of strategic market insights. We offer executive-level blueprints of markets and solutions beyond flagship surveys. Our repository covers consultation, syndicated market studies, and customized research reports. Through our services, we aim at connecting an organization’s goal with lucrative prospects globally.

Related Articles

Back to top button